Larimar Therapeutics (LRMR) Current Assets (2016 - 2020)
Historic Current Assets for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $107.8 million.
- Larimar Therapeutics' Current Assets rose 2920.92% to $107.8 million in Q3 2020 from the same period last year, while for Sep 2020 it was $107.8 million, marking a year-over-year increase of 2920.92%. This contributed to the annual value of $4.8 million for FY2019, which is 9608.51% down from last year.
- Latest data reveals that Larimar Therapeutics reported Current Assets of $107.8 million as of Q3 2020, which was up 2920.92% from $119.1 million recorded in Q2 2020.
- Larimar Therapeutics' Current Assets' 5-year high stood at $168.8 million during Q1 2016, with a 5-year trough of $4.8 million in Q4 2019.
- Its 5-year average for Current Assets is $106.6 million, with a median of $107.8 million in 2020.
- Its Current Assets has fluctuated over the past 5 years, first surged by 3743.94% in 2018, then crashed by 9608.51% in 2019.
- Over the past 5 years, Larimar Therapeutics' Current Assets (Quarter) stood at $130.9 million in 2016, then fell by 19.84% to $104.9 million in 2017, then increased by 15.63% to $121.3 million in 2018, then tumbled by 96.09% to $4.8 million in 2019, then surged by 2169.81% to $107.8 million in 2020.
- Its last three reported values are $107.8 million in Q3 2020, $119.1 million for Q2 2020, and $64.7 million during Q1 2020.